Home›People›John Liles
John Liles

John Liles

VP Biology & Translational Science at Moonwalk Biosciences.

Executive
Updated Nov 9, 2026·Latest SEC filing Sep 14, 2026·Suggest an edit

About John Liles

John Liles is VP Biology & Translational Science at Moonwalk Biosciences.

Experience

This experience comes from John Liles's profile and from SEC filings. For roles taken from filings, the years are when the filings name John Liles in the role, so the role may have started earlier or lasted longer.

Moonwalk Biosciences, Inc. Current
VP Biology & Translational Science
2024 – Present · South San Francisco, CA
Develops fat-tissue-targeted therapies for people with obesity and cardiometabolic diseases.
Chinook Therapeutics, Inc.
Executive Director, Kidney Disease Research Strategy
2022 – 2024
Gilead Sciences
Director
2007 – 2022
National Academy of Sciences
National Research Council Post-Doc
2005 – 2007

Key Colleagues at Startups

The people John Liles works with at each company, as listed on that company's latest Form D.

Moonwalk Biosciences, Inc. · Form D, Sep 14, 2026
Chris Dimitropoulos
Chris Dimitropoulos
Managing Director, Alpha Wave Global
AJ
Arash Jamshidi
President and director
AA
Alexander Aravanis
Executive officer and director
Justin Valley
Justin Valley
Co-Founder, Chief Platform Officer
SD
Stephen Djedjos
Executive officer
PB
Paul Burton
Director
EC
Elaine Cheung
Executive officer

Sources

  1. SECMoonwalk Biosciences, Inc. Form D, filed Sep 14, 2026